Gjør som tusenvis av andre bokelskere
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.Du kan når som helst melde deg av våre nyhetsbrev.
Presents an account of how the psychotropic drug Halcion came onto the market in the UK and the US, and how it was subsequently withdrawn in the UK after having serious effects on many patients - such as amnesia, suicidal behaviour and psychosis.
Controlling Pharmaceutical Risks analyses changes in drug testing since the late 1990s, specifically geneticization of carcinogenic risk assessment and regulation of pharmaceuticals, involving issues fundamental to bio-science, medical treatment and patients¿ health, such as what knowledge is judged necessary to determine carcinogenic risk to humans, and how that judgement transpired.
This book presents a critical appraisal of medicines regulation policy and exposes the influence of the pharmaceutical industry in the acceleration of drug approvals.
A systematic investigation of bias in scientific research, based on a rigorous examination of documentary sources on drug controversies. The book offers a comparison of medicine testing and regulation in the UK and US from a social science perspective.
This text examines how the ideals of comprehensive education are articulated, challenged and reproduced through social class and gender divisions within secondary education. Topics such as the attitudes of anti-school pupils and teachers' gender stereotyping are addressed.
Abonner på vårt nyhetsbrev og få rabatter og inspirasjon til din neste leseopplevelse.
Ved å abonnere godtar du vår personvernerklæring.